Yoshiki Sakai

1PUBLICATIONS
5CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Mar 27, 2026
Docetaxel for Pembrolizumab-Refractory Recurrent Basal Cell Carcinoma.

Yoshiki Sakai, Dai Ogata, Michitoshi Kurisaki

Pageof 1

Frequent Collaborators

1 joint publications

Dai Ogata

1 joint publications

Harutaka Seshimo

1 joint publications

Eiji Nakano

1 joint publications

Naoya Yamazaki